Does N32.81 require prior authorization?

No, N32.81 does not require prior authorization (high confidence). Covered without prior authorization.

`N32.81`, Overactive bladder

ICD-10-CM

No Prior Auth Required

Covered without prior authorization (high confidence)

All documentation must be maintained in the patient's medical record, legible, include patient identification (e.g., full name, dates of service), and be made available to the contractor upon request.
The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care.
The submitted medical record must support the selected ICD-10-CM code(s), the submitted CPT/HCPCS code must describe the service performed, and the record must clearly document medical necessity, the indication for ordering the test, and a clear diagnostic impression.
If documentation is requested, providers must submit a hard copy of waveforms and/or a complete written report with interpretation sufficient to support that the test was medically reasonable and necessary.

Nerve conduction studies (NCS) without needle EMG (NEMG) are allowed for individuals being evaluated for carpal tunnel syndrome or tarsal tunnel syndrome when one of the following ICD-10-CM codes is reported: G56.01, G56.02, G56.03, G56.11, G56.12, G56.13, G56.21, G56.22, G56.23, G57.51, G57.52, or G57.53.
NCS without NEMG is allowed for individuals with significant lymphedema in the affected extremity when ICD-10-CM code I89.0 is reported in addition to the primary diagnosis.
NCS without NEMG is allowed for individuals treated with anticoagulants when ICD-10-CM code Z79.01 or Z79.02 is reported in addition to the primary diagnosis.
Posterior tibial nerve stimulation (PTNS) is covered for patients with overactive bladder syndrome (OBS)/overactive bladder (OAB) per the International Continence Society definition (urinary urgency, usually with frequency and nocturia, with or without urgency urinary incontinence, absent UTI or other obvious pathology).
PTNS is covered only for non-neurogenic, non-stress urinary incontinence etiologies (i.e., patient must NOT have stress or neurogenic incontinence).
PTNS is covered when the patient has documented inadequate improvement after appropriate first- and second-line therapies, as evidenced by compliance and a minimum 3-day voiding diary prior to initiation.

CGS-J15-L39857, Botulinum Toxin Injections

J15

CGS-J15-L34056, Urodynamics

J15

CGS-J18-L34056, Urodynamics

J18

CGS-J18-L39857, Botulinum Toxin Injections

J18

WPS-J5-L40381, Botulinum Toxin Injections

Ask Backwork about documentation requirements, denial risks, or coverage in your state.